BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zhang XX, Wang LF, Jin L, Li YY, Hao SL, Shi YC, Zeng QL, Li ZW, Zhang Z, Lau GK, Wang FS. Primary biliary cirrhosis-associated hepatocellular carcinoma in Chinese patients: Incidence and risk factors. World J Gastroenterol 2015; 21(12): 3554-3563 [PMID: 25834320 DOI: 10.3748/wjg.v21.i12.3554]
URL: https://www.wjgnet.com/1007-9327/full/v21/i12/3554.htm
Number Citing Articles
1
Xuping Wu, Qi Wang, Yousheng Lu, Jinye Zhang, Hanwei Yin, Yongxiang Yi. Clinical application of thioredoxin reductase as a novel biomarker in liver cancerScientific Reports 2021; 11(1) doi: 10.1038/s41598-021-85688-3
2
Hannes Hagström. Alcohol Consumption in Concomitant Liver Disease: How Much is Too Much?Current Hepatology Reports 2017; 16(2): 152 doi: 10.1007/s11901-017-0343-0
3
Hyun-seok Kim, Hashem B. El-Serag. The Epidemiology of Hepatocellular Carcinoma in the USACurrent Gastroenterology Reports 2019; 21(4) doi: 10.1007/s11894-019-0681-x
4
Sylvia Drazilova, Ingrid Babinska, Jakub Gazda, Monika Halanova, Martin Janicko, Branislav Kucinsky, Dominik Safcak, Dominika Martinkova, Lucia Tarbajova, Anna Cekanova, Peter Jarcuska. Epidemiology and clinical course of primary biliary cholangitis in Eastern SlovakiaInternational Journal of Public Health 2020; 65(5): 683 doi: 10.1007/s00038-020-01391-6
5
Lifeng Wang, Christopher L. Bowlus, Fu-Sheng Wang, M. Eric Gershwin. Biliary Disease2017; : 129 doi: 10.1007/978-3-319-50168-0_8
6
Hannes Hagström. Alcohol, smoking and the liver disease patientBest Practice & Research Clinical Gastroenterology 2017; 31(5): 537 doi: 10.1016/j.bpg.2017.09.003
7
Cristina Micali, Ylenia Russotto, Grazia Caci, Manuela Ceccarelli, Andrea Marino, Benedetto Maurizio Celesia, Giovanni Francesco Pellicanò, Giuseppe Nunnari, Emmanuele Venanzi Rullo. Loco-Regional Treatments for Hepatocellular Carcinoma in People Living with HIVInfectious Disease Reports 2022; 14(1): 43 doi: 10.3390/idr14010006
8
Christine C. Hsu, Kris V. Kowdley. The Effects of Alcohol on Other Chronic Liver DiseasesClinics in Liver Disease 2016; 20(3): 581 doi: 10.1016/j.cld.2016.02.013
9
Michael Chew, Christopher L. Bowlus. Primary biliary cholangitis: Diagnosis and treatmentLiver Research 2018; 2(2): 81 doi: 10.1016/j.livres.2018.03.004
10
Yamini Natarajan, Aylin Tansel, Parth Patel, Kingsley Emologu, Richa Shukla, Zeeshan Qureshi, Hashem B. El-Serag, Aaron P. Thrift, Fasiha Kanwal. Incidence of Hepatocellular Carcinoma in Primary Biliary Cholangitis: A Systematic Review and Meta-AnalysisDigestive Diseases and Sciences 2021; 66(7): 2439 doi: 10.1007/s10620-020-06498-7
11
Ziqian Xu, Wan Tang, Qiaoling Xie, Xinyu Cao, Mengni Zhang, Xiaoxun Zhang, Jin Chai. Dimethyl fumarate attenuates cholestatic liver injury by activating the NRF2 and FXR pathways and suppressing NLRP3/GSDMD signaling in miceExperimental Cell Research 2023; 432(2): 113781 doi: 10.1016/j.yexcr.2023.113781
12
Ying-Qiu Huang. Recent advances in the diagnosis and treatment of primary biliary cholangitisWorld Journal of Hepatology 2016; 8(33): 1419-1441 doi: 10.4254/wjh.v8.i33.1419
13
Dustin E. Bosch, Yoh Zen, Sarag A. Boukhar, Yongjun Liu, Lin Cheng, Matthew M. Yeh. Hepatocellular carcinoma in primary sclerosing cholangitis and primary biliary cholangitis: a clinical and pathological study in an uncommon but emerging settingVirchows Archiv 2021; 479(6): 1131 doi: 10.1007/s00428-021-03183-6
14
Kazuo Tarao, Akito Nozaki, Takaaki Ikeda, Akira Sato, Hirokazu Komatsu, Tatsuji Komatsu, Masataka Taguri, Katsuaki Tanaka. Real impact of liver cirrhosis on the development of hepatocellular carcinoma in various liver diseases—meta‐analytic assessmentCancer Medicine 2019; 8(3): 1054 doi: 10.1002/cam4.1998
15
Costin Teodor Streba, Cristin Constantin Vere, Ion Rogoveanu, Nicu Dan Florescu. Hepatocellular Carcinoma - Advances in Diagnosis and Treatment2018;  doi: 10.5772/intechopen.78328
16
Meaghan Phipps, Alexandra Livanos, Averill Guo, Sydney Pomenti, Jonathan Yeh, Lara Dakhoul, Heather Burney, Carla Kettler, Hao Liu, Ethan Miller, Samer Gawrieh, Andrew deLemos, Andrew Scanga, Naga Chalasani, Julia Wattacheril. Gender Matters: Characteristics of Hepatocellular Carcinoma in Women From a Large, Multicenter Study in the United StatesAmerican Journal of Gastroenterology 2020; 115(9): 1486 doi: 10.14309/ajg.0000000000000643
17
Hai-Chun Zhang, Rong-Fei Hu, Ting Zhu, Ling Tong, Qiu-Qin Zhang. Primary biliary cirrhosis degree assessment by acoustic radiation force impulse imaging and hepatic fibrosis indicatorsWorld Journal of Gastroenterology 2016; 22(22): 5276-5284 doi: 10.3748/wjg.v22.i22.5276
18
Ana Lleo, Giu-Qiang Wang, Merrill Eric Gershwin, Gideon M Hirschfield. Primary biliary cholangitisThe Lancet 2020; 396(10266): 1915 doi: 10.1016/S0140-6736(20)31607-X
19
Sainan Bian, Li Wang, Yunyun Fei, Suying Liu, Hua Chen, Fengchun Zhang. The clinical and laboratory features associated with cancer in patients with primary biliary cholangitis: a longitudinal survey–based studyClinical Rheumatology 2021; 40(8): 3311 doi: 10.1007/s10067-021-05657-z
20
Honglin Xu, Ziyan Wu, Futai Feng, Yongzhe Li, Shulan Zhang. Low vitamin D concentrations and BMI are causal factors for primary biliary cholangitis: A mendelian randomization studyFrontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.1055953
21
Aylin Tansel, Lior H. Katz, Hashem B. El-Serag, Aaron P. Thrift, Mayur Parepally, Mohammad H. Shakhatreh, Fasiha Kanwal. Incidence and Determinants of Hepatocellular Carcinoma in Autoimmune Hepatitis: A Systematic Review and Meta-analysisClinical Gastroenterology and Hepatology 2017; 15(8): 1207 doi: 10.1016/j.cgh.2017.02.006
22
Na Zeng, Weijia Duan, Sha Chen, Shanshan Wu, Hong Ma, Xiaojuan Ou, Hong You, Yuanyuan Kong, Jidong Jia. Epidemiology and clinical course of primary biliary cholangitis in the Asia–Pacific region: a systematic review and meta-analysisHepatology International 2019; 13(6): 788 doi: 10.1007/s12072-019-09984-x
23
Annarosa Floreani, Daniela Gabbia, Sara De Martin. Current Perspectives on the Molecular and Clinical Relationships between Primary Biliary Cholangitis and Hepatocellular CarcinomaInternational Journal of Molecular Sciences 2024; 25(4): 2194 doi: 10.3390/ijms25042194
24
Eirini I. Rigopoulou, George N. Dalekos. Current Trends and Characteristics of Hepatocellular Carcinoma in Patients with Autoimmune Liver DiseasesCancers 2021; 13(5): 1023 doi: 10.3390/cancers13051023
25
Alexander M. Sy, Raphaella D. Ferreira, Binu V. John. Hepatocellular Carcinoma in Primary Biliary CholangitisClinics in Liver Disease 2022; 26(4): 691 doi: 10.1016/j.cld.2022.06.011
26
Michelle Harriz Braga, Guilherme Grossi Lopes Cançado, Paulo Lisboa Bittencourt, Cláudia Alves Couto, Laura Vilar Guedes, André Mourão Costa Lima, Maria Lucia Gomes Ferraz, Cristiane Alves Villela-Nogueira, Mateus Jorge Nardelli, Luciana Costa Faria, Nathalia Mota de Faria Gomes, Elze Maria Gomes Oliveira, Vivian Rotman, Maria Beatriz Oliveira, Simone Muniz Carvalho Fernandes da Cunha, Marlone Cunha-Silva, Liliana Sampaio Costa Mendes, Claudia Alexandra Pontes Ivantes, Liana Codes, Valéria Ferreira de Almeida e Borges, Fabio Heleno de Lima Pace, Mario Guimarães Pessoa, Izabelle Venturini Signorelli, Gabriela Perdomo Coral, João Galizzi Filho, Aline Lopes Chagas, Debora Raquel Benedita Terrabuio, Eduardo Luiz Rachid Cançado. Risk factors for cancer in patients with primary biliary cholangitis and autoimmune hepatitis and primary biliary cholangitis overlap syndromeAnnals of Hepatology 2023; 28(4): 101105 doi: 10.1016/j.aohep.2023.101105
27
Qingshui Huang, Shuai Chu, Xiaofeng Yin, Xiaobin Yu, Chunmin Kang, Xin Li, Yurong Qiu. Interleukin-17A-Induced Epithelial-Mesenchymal Transition of Human Intrahepatic Biliary Epithelial Cells: Implications for Primary Biliary CirrhosisThe Tohoku Journal of Experimental Medicine 2016; 240(4): 269 doi: 10.1620/tjem.240.269
28
Blaire E. Burman, Manan A. Jhaveri, Kris V. Kowdley. An Update on the Treatment and Follow-up of Patients with Primary Biliary CholangitisClinics in Liver Disease 2017; 21(4): 709 doi: 10.1016/j.cld.2017.06.005